Cargando…

SAT273 Characterizing The Diurnal Rhythm And Duration Of Adrenal Suppression Following Weeklong Corticosterone Treatment And Withdrawal

Disclosure: C.N. Snyder: None. J.L. Spencer-Segal: None. Exogenous or endogenous glucocorticoid can create a dependence on glucocorticoid excess that manifests as a withdrawal syndrome during attempted taper. The etiology of this syndrome is unclear, and mechanistic understanding is hampered by the...

Descripción completa

Detalles Bibliográficos
Autores principales: Snyder, Christen N, Spencer-Segal, Joanna L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553581/
http://dx.doi.org/10.1210/jendso/bvad114.278
_version_ 1785116205214859264
author Snyder, Christen N
Spencer-Segal, Joanna L
author_facet Snyder, Christen N
Spencer-Segal, Joanna L
author_sort Snyder, Christen N
collection PubMed
description Disclosure: C.N. Snyder: None. J.L. Spencer-Segal: None. Exogenous or endogenous glucocorticoid can create a dependence on glucocorticoid excess that manifests as a withdrawal syndrome during attempted taper. The etiology of this syndrome is unclear, and mechanistic understanding is hampered by the lack of a suitable mouse model. Here we present results from one attempt to define a suitable mouse model of chronic glucocorticoid excess and withdrawal. Male mice were treated with corticosterone (45μg/mL) in 1% ethanol in the drinking water for one week prior to withdrawal to a lower dose (10μg/mL) or complete withdrawal (vehicle). Control groups received vehicle or corticosterone 45μg/mL without withdrawal. Tail vein blood samples were collected from mice numerous times during the withdrawal and plasma levels of corticosterone were measured using an Enzyme Immunoassay (Arbor Assays) to determine circulating levels of corticosterone achieved at the diurnal peak and trough during treatment and withdrawal. There were three main goals of this study: (1) measure the circulating levels of corticosterone achieved at the peak and trough using this treatment paradigm (2) determine if 10μg/mL was a physiologic dose during the withdrawal period, and (3) to determine the duration of HPA axis suppression. Results showed that the diurnal rhythm of corticosterone in the treated mice was the opposite of control such that corticosterone levels were high in the morning and low in the evening. Corticosterone levels returned to control levels within 24 hours of withdrawal to 10μg/mL. When withdrawn completely, corticosterone levels decrease below control levels twenty-four hours into the withdrawal but begin to return to baseline by seventy-two hours post-withdrawal indicating rapid recovery of the endogenous HPA axis. This shows that providing corticosterone to mice in the drinking water alters the diurnal peak and trough of circulating corticosterone without continuous corticosterone elevation or prolonged HPA axis suppression. This disruption of the diurnal peak and trough should be considered in the interpretation of studies using chronic corticosterone in the drinking water. Further, this model may not be suitable for studying glucocorticoid withdrawal from chronic excess as the level of corticosterone drops below control at time points in this treatment model. Presentation: Saturday, June 17, 2023
format Online
Article
Text
id pubmed-10553581
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-105535812023-10-06 SAT273 Characterizing The Diurnal Rhythm And Duration Of Adrenal Suppression Following Weeklong Corticosterone Treatment And Withdrawal Snyder, Christen N Spencer-Segal, Joanna L J Endocr Soc Adrenal (Excluding Mineralocorticoids) Disclosure: C.N. Snyder: None. J.L. Spencer-Segal: None. Exogenous or endogenous glucocorticoid can create a dependence on glucocorticoid excess that manifests as a withdrawal syndrome during attempted taper. The etiology of this syndrome is unclear, and mechanistic understanding is hampered by the lack of a suitable mouse model. Here we present results from one attempt to define a suitable mouse model of chronic glucocorticoid excess and withdrawal. Male mice were treated with corticosterone (45μg/mL) in 1% ethanol in the drinking water for one week prior to withdrawal to a lower dose (10μg/mL) or complete withdrawal (vehicle). Control groups received vehicle or corticosterone 45μg/mL without withdrawal. Tail vein blood samples were collected from mice numerous times during the withdrawal and plasma levels of corticosterone were measured using an Enzyme Immunoassay (Arbor Assays) to determine circulating levels of corticosterone achieved at the diurnal peak and trough during treatment and withdrawal. There were three main goals of this study: (1) measure the circulating levels of corticosterone achieved at the peak and trough using this treatment paradigm (2) determine if 10μg/mL was a physiologic dose during the withdrawal period, and (3) to determine the duration of HPA axis suppression. Results showed that the diurnal rhythm of corticosterone in the treated mice was the opposite of control such that corticosterone levels were high in the morning and low in the evening. Corticosterone levels returned to control levels within 24 hours of withdrawal to 10μg/mL. When withdrawn completely, corticosterone levels decrease below control levels twenty-four hours into the withdrawal but begin to return to baseline by seventy-two hours post-withdrawal indicating rapid recovery of the endogenous HPA axis. This shows that providing corticosterone to mice in the drinking water alters the diurnal peak and trough of circulating corticosterone without continuous corticosterone elevation or prolonged HPA axis suppression. This disruption of the diurnal peak and trough should be considered in the interpretation of studies using chronic corticosterone in the drinking water. Further, this model may not be suitable for studying glucocorticoid withdrawal from chronic excess as the level of corticosterone drops below control at time points in this treatment model. Presentation: Saturday, June 17, 2023 Oxford University Press 2023-10-05 /pmc/articles/PMC10553581/ http://dx.doi.org/10.1210/jendso/bvad114.278 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Adrenal (Excluding Mineralocorticoids)
Snyder, Christen N
Spencer-Segal, Joanna L
SAT273 Characterizing The Diurnal Rhythm And Duration Of Adrenal Suppression Following Weeklong Corticosterone Treatment And Withdrawal
title SAT273 Characterizing The Diurnal Rhythm And Duration Of Adrenal Suppression Following Weeklong Corticosterone Treatment And Withdrawal
title_full SAT273 Characterizing The Diurnal Rhythm And Duration Of Adrenal Suppression Following Weeklong Corticosterone Treatment And Withdrawal
title_fullStr SAT273 Characterizing The Diurnal Rhythm And Duration Of Adrenal Suppression Following Weeklong Corticosterone Treatment And Withdrawal
title_full_unstemmed SAT273 Characterizing The Diurnal Rhythm And Duration Of Adrenal Suppression Following Weeklong Corticosterone Treatment And Withdrawal
title_short SAT273 Characterizing The Diurnal Rhythm And Duration Of Adrenal Suppression Following Weeklong Corticosterone Treatment And Withdrawal
title_sort sat273 characterizing the diurnal rhythm and duration of adrenal suppression following weeklong corticosterone treatment and withdrawal
topic Adrenal (Excluding Mineralocorticoids)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553581/
http://dx.doi.org/10.1210/jendso/bvad114.278
work_keys_str_mv AT snyderchristenn sat273characterizingthediurnalrhythmanddurationofadrenalsuppressionfollowingweeklongcorticosteronetreatmentandwithdrawal
AT spencersegaljoannal sat273characterizingthediurnalrhythmanddurationofadrenalsuppressionfollowingweeklongcorticosteronetreatmentandwithdrawal